The Oncosearch | Oncotarget

Sustained response of three pediatric BRAF^V600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy Case Report

Stephanie A. Toll, Hung N. Tran, Jennifer Cotter, Alexander R. Judkins, Benita Tamrazi, Jaclyn A Biegel, Girish Dhall, Nathan J. Robison, Kaaren Waters, Palak Patel, Robert Cooper, Ashley S. Margol

Published Jan 11, 2019 · Vol. 10, No. 4 · pp. 551-557

Transducin-like enhancer of split 3 regulates proliferation of melanoma cells via histone deacetylase activity Research Paper

Masahiro Ogawa, Tatsuki Yaginuma, Chihiro Nakatomi, Tsuyoshi Nakajima, Yukiyo Tada-Shigeyama, William N. Addison, Mariko Urata, Takuma Matsubara, Koji Watanabe, Kou Matsuo, Tsuyoshi Sato, Hiromi Honda, Hisako Hikiji, Seiji Watanabe, Shoichiro Kokabu

Published Jan 8, 2019 · Vol. 10, No. 3 · pp. 404-414

Monitoring melanoma recurrence with circulating tumor DNA: a proof of concept from three case studies Research Paper

Ashleigh C. McEvoy, Michelle R. Pereira, Anna Reid, Robert Pearce, Lester Cowell, Zeyad Al-Ogaili, Muhammad A. Khattak, Michael Millward, Tarek M. Meniawy, Elin S. Gray, Melanie Ziman

Published Jan 4, 2019 · Vol. 10, No. 2 · pp. 113-122

TNFα mediated ceramide generation triggers cisplatin induced apoptosis in B16F10 melanoma in a PKCδ independent manner Research Paper

Sweta Ghosh, Junaid Jibran Jawed, Kuntal Halder, Sayantan Banerjee, Bidisha Paul Chowdhury, Akata Saha, Subir Kumar Juin, Suchandra Bhattacharyya Majumdar, Anamika Bose, Rathindranath Baral, Subrata Majumdar

Published Dec 28, 2018 · Vol. 9, No. 102 · pp. 37627-37646

Divergent roles of lysyl oxidase family members in ornithine decarboxylase- and RAS-transformed mouse fibroblasts and human melanoma cells Research Paper

Mari Kielosto, Johanna Eriksson, Pirjo Nummela, Miao Yin, Erkki HÃ¶lttÃ¤

Published Dec 28, 2018 · Vol. 9, No. 102 · pp. 37733-37752

Phosphorylated Akt1 expression is associated with poor prognosis in cutaneous, oral and sinonasal melanomas Research Paper

Ciro Soares, ThaynÃ¡ Melo de Lima Morais, Roman Carlos, Fernanda Viviane Mariano, Albina Altemani, Maria Goretti Freire de Carvalho, Marcelo Brum CorrÃªa, Rodrigo Ribas Dias dos Reis, Luciana Schultz Amorim, Oslei Paes de Almeida, Jacks Jorge

Published Dec 18, 2018 · Vol. 9, No. 99 · pp. 37291-37304

Targeting melanoma residual disease by USP7 Editorial

Monika Vishnoi, Dario Marchetti

Published Dec 15, 2018 · Vol. 9, No. 101 · pp. 37464-37465

Microenvironment-derived ADAM28 prevents cancer dissemination Research Paper

Catherine GÃ©rard, CÃ©line Hubeau, Oriane Carnet, Marine Bellefroid, Nor Eddine Sounni, Silvia Blacher, Guillaume Bendavid, Markus Moser, Reinhard FÃ¤ssler, AgnÃ¨s Noel, Didier Cataldo, Natacha Rocks

Published Dec 14, 2018 · Vol. 9, No. 98 · pp. 37185-37199

UBE2N plays a pivotal role in maintaining melanoma malignancy Editorial

Anushka Dikshit, Jennifer Y. Zhang

Published Dec 12, 2018 · Vol. 9, No. 100 · pp. 37347-37348

Correction: BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells Correction

Erminia Romano, Nicole Rufo, Hannelie Korf, Chantal Mathieu, Abhishek D. Garg, Patrizia Agostinis

Published Dec 11, 2018 · Vol. 9, No. 97 · pp. 37076-37076

NEO412: A temozolomide analog with transdermal activity in melanoma in vitro and in vivo Research Paper

Steve Swenson, Catalina Silva-Hirschberg, Weijun Wang, Anupam Singh, Florence M. Hofman, Kristen L. Chen, Axel H. SchÃ¶nthal, Thomas C. Chen

Published Dec 11, 2018 · Vol. 9, No. 97 · pp. 37026-37041

Bioenergetic modulation with the mitochondria uncouplers SR4 and niclosamide prevents proliferation and growth of treatment-naïve and vemurafenib-resistant melanomas Research Paper

James L. Figarola, Jyotsana Singhal, Sharad Singhal, Jyotirmoy Kusari, Arthur Riggs

Published Dec 11, 2018 · Vol. 9, No. 97 · pp. 36945-36965

Correction: Cutaneous melanoma primary site is linked to nevus density Correction

Alejandro Martin-Gorgojo, Marta Llinares, Amaya VirÃ³s, Celia Requena, Zaida Garcia-Casado, VÃctor Traves, Rajiv Kumar, Eduardo Nagore

Published Dec 4, 2018 · Vol. 9, No. 95 · pp. 36816-36816

Correction: The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth Correction

Kimberley Hanson, Stephen D. Robinson, Karamallah Al-Yousuf, Adam E. Hendry, Darren W. Sexton, Victoria Sherwood, Grant N. Wheeler

Published Nov 27, 2018 · Vol. 9, No. 93 · pp. 36645-36645

Monitoring BRAF and NRAS mutations with cell-free circulating tumor DNA from metastatic melanoma patients Research Paper

Elodie Long-Mira, Marius Ilie, Emmanuel Chamorey, Florence Leduff-Blanc, Henri MontaudiÃ©, Virginie Tanga, Maryline AllÃ©gra, Virginie Lespinet-Fabre, Olivier Bordone, Christelle Bonnetaud, Renaud Schiappa, Catherine Butori, Coraline Bence, Jean-Philippe Lacour, VÃ©ronique Hofman, Paul Hofman

Published Nov 16, 2018 · Vol. 9, No. 90 · pp. 36238-36249

Correction: Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma Correction

Jon Bjoern, Rikke Lyngaa, Rikke Andersen, Lisbet HÃ¶lmich Rosenkrantz, Sine Reker Hadrup, Marco Donia, Inge Marie Svane

Published Nov 9, 2018 · Vol. 9, No. 88 · pp. 35870-35870

New insights in melanoma resistance to BRAF inhibitors: a role for microRNAs Editorial

Marta DÃaz-MartÃnez, LucÃa Benito-JardÃ³n, Joaquin TeixidÃ³

Published Oct 14, 2018 · Vol. 9, No. 83 · pp. 35374-35375

Molecular analysis of the dual targeting of the epidermal growth factor receptor and the O⁶-methylguanine-DNA methyltransferase with a double arm hybrid molecule Research Paper

Martin Rupp, Zhor Senhaji Mouhri, Christopher Williams, Bertrand J. Jean-Claude

Published Oct 12, 2018 · Vol. 9, No. 80 · pp. 35041-35055

MEK/CDK4,6 co-targeting is effective in a subset of NRAS, BRAF and 'wild type' melanomas Research Paper

Christian Posch, Martina Sanlorenzo, Jeffrey Ma, Sarasa T. Kim, Mitchell Zekhtser, Susana Ortiz-Urda

Published Oct 9, 2018 · Vol. 9, No. 79 · pp. 34990-34995

The efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma: A retrospective multicenter study Research Paper

Julia K. Tietze, Andrea Forschner, Carmen Loquai, Heidrun Mitzel-Rink, Lisa Zimmer, Frank Meiss, David Rafei-Shamsabadi, Jochen Utikal, Maike Bergmann, Friedegund Meier, Nicole Kreuzberg, Max Schlaak, Carsten Weishaupt, Claudia PfÃ¶hler, Mirjana Ziemer, Michael Fluck, Jessica Rainer, Markus V. Heppt, Carola Berking

Published Sep 28, 2018 · Vol. 9, No. 76 · pp. 34336-34346

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Sustained response of three pediatric BRAF^V600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy Case Report

Transducin-like enhancer of split 3 regulates proliferation of melanoma cells via histone deacetylase activity Research Paper

Monitoring melanoma recurrence with circulating tumor DNA: a proof of concept from three case studies Research Paper

TNFα mediated ceramide generation triggers cisplatin induced apoptosis in B16F10 melanoma in a PKCδ independent manner Research Paper

Divergent roles of lysyl oxidase family members in ornithine decarboxylase- and RAS-transformed mouse fibroblasts and human melanoma cells Research Paper

Phosphorylated Akt1 expression is associated with poor prognosis in cutaneous, oral and sinonasal melanomas Research Paper

Targeting melanoma residual disease by USP7 Editorial

Microenvironment-derived ADAM28 prevents cancer dissemination Research Paper

UBE2N plays a pivotal role in maintaining melanoma malignancy Editorial

Correction: BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells Correction

NEO412: A temozolomide analog with transdermal activity in melanoma in vitro and in vivo Research Paper

Bioenergetic modulation with the mitochondria uncouplers SR4 and niclosamide prevents proliferation and growth of treatment-naïve and vemurafenib-resistant melanomas Research Paper

Correction: Cutaneous melanoma primary site is linked to nevus density Correction

Correction: The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth Correction

Monitoring BRAF and NRAS mutations with cell-free circulating tumor DNA from metastatic melanoma patients Research Paper

Correction: Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma Correction

New insights in melanoma resistance to BRAF inhibitors: a role for microRNAs Editorial

Molecular analysis of the dual targeting of the epidermal growth factor receptor and the O⁶-methylguanine-DNA methyltransferase with a double arm hybrid molecule Research Paper

MEK/CDK4,6 co-targeting is effective in a subset of NRAS, BRAF and 'wild type' melanomas Research Paper

The efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma: A retrospective multicenter study Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Sustained response of three pediatric BRAFV600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy Case Report

Transducin-like enhancer of split 3 regulates proliferation of melanoma cells via histone deacetylase activity Research Paper

Monitoring melanoma recurrence with circulating tumor DNA: a proof of concept from three case studies Research Paper

TNFα mediated ceramide generation triggers cisplatin induced apoptosis in B16F10 melanoma in a PKCδ independent manner Research Paper

Divergent roles of lysyl oxidase family members in ornithine decarboxylase- and RAS-transformed mouse fibroblasts and human melanoma cells Research Paper

Phosphorylated Akt1 expression is associated with poor prognosis in cutaneous, oral and sinonasal melanomas Research Paper

Targeting melanoma residual disease by USP7 Editorial

Microenvironment-derived ADAM28 prevents cancer dissemination Research Paper

UBE2N plays a pivotal role in maintaining melanoma malignancy Editorial

Correction: BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells Correction

NEO412: A temozolomide analog with transdermal activity in melanoma in vitro and in vivo Research Paper

Bioenergetic modulation with the mitochondria uncouplers SR4 and niclosamide prevents proliferation and growth of treatment-naïve and vemurafenib-resistant melanomas Research Paper

Correction: Cutaneous melanoma primary site is linked to nevus density Correction

Correction: The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth Correction

Monitoring BRAF and NRAS mutations with cell-free circulating tumor DNA from metastatic melanoma patients Research Paper

Correction: Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma Correction

New insights in melanoma resistance to BRAF inhibitors: a role for microRNAs Editorial

Molecular analysis of the dual targeting of the epidermal growth factor receptor and the O6-methylguanine-DNA methyltransferase with a double arm hybrid molecule Research Paper

MEK/CDK4,6 co-targeting is effective in a subset of NRAS, BRAF and 'wild type' melanomas Research Paper

The efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma: A retrospective multicenter study Research Paper

Sustained response of three pediatric BRAF^V600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy Case Report

Molecular analysis of the dual targeting of the epidermal growth factor receptor and the O⁶-methylguanine-DNA methyltransferase with a double arm hybrid molecule Research Paper